![]() |
市場調查報告書
商品編碼
1916642
眼部健康和視力支援產品市場預測至2032年:按產品類型、配方、通路、應用、最終用戶和地區分類的全球分析Eye Health & Vision Support Products Market Forecasts to 2032 - Global Analysis By Product Type (Dietary Supplements, Vision Support Devices & Products, and Other Product Types), Formulation, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球眼部健康和視力支援產品市場價值將達到 21.4 億美元,到 2032 年將達到 35.1 億美元,在預測期內的複合年成長率為 7.3%。
眼部健康和視力支援產品包括旨在促進健康視力和最佳眼部功能的消費者解決方案。此類別涵蓋營養補充品、強化食品和飲料、眼部護理產品以及含有必需營養素和生物活性化合物的視力保護解決方案。這些產品旨在減輕眼部疲勞、緩解眼幹、對抗電子螢幕照射並老齡化相關的視力衰退。透過支援日常眼部舒適度和長期眼部功能,我們滿足了不同族群的預防性醫療保健需求。
預防性醫療保健的興起
消費者越來越意識到定期眼部護理對於預防視力喪失和老齡化性眼科疾病的重要性。螢幕使用時間的增加、生活方式導致的眼睛疲勞以及視力障礙的早期出現,都促使人們積極採取營養補充和眼部保健措施。各國政府和醫療機構正在推廣預防性視力檢查和營養支援。診斷技術的進步使得眼科疾病的早期發現成為可能,進一步加強了預防措施。葉黃素、玉米黃素和Omega-3脂肪酸等功能性成分因其長期保護眼睛的作用而日益受到歡迎。這種預防導向的轉變正在推動已開發市場和新興市場持續成長。
缺乏長期臨床證據
許多膳食補充劑依賴短期研究,而這些研究不足以充分證明其持久療效。監管機構通常要求提供可靠的科學證據,這給產品核可和功效聲明的證實帶來了挑戰。此外,由於研究結果因目標族群而異,一致性問題也日益受到關注。醫療保健專業人員可能不願意推薦缺乏強而有力臨床支援的產品。這種不確定性可能會降低消費者信心,並減緩產品的普及。因此,市場相關人員被迫投入大量資金進行研究,以提升產品的可信度。
個人化視力保健
基因組學、數位眼科診斷和人工智慧驅動的評估技術的進步,正推動著個人化眼科護理解決方案的實現。消費者越來越傾向於根據自身年齡、生活方式和特定視覺需求,尋求客製化的營養補充品和處方箋。穿戴式裝置和行動應用程式正助力實現眼部健康的個人化監測。企業正利用數據分析,開發針對乾眼症、藍光照射和黃斑健康等疾病的專用產品。這種個人化服務提高了治療效果和客戶參與。隨著精準醫療的擴展,個人化視力保健預計將變得越來越普及。
產品召回和品管問題
眼部保健品必須嚴格遵守安全和品質標準,以避免有害影響。污染、標籤不準確或成分品質波動都可能引發監管行動。產品召回不僅會造成經濟損失,還會損害品牌聲譽。全球對膳食補充劑生產的審查日益嚴格,並加大了合規壓力。供應鏈的複雜性進一步增加了品管缺失的風險。如果沒有健全的品管體系,企業可能會面臨長期的信任危機。
新冠感染疾病對眼部健康和視力保護產品市場產生了複雜的影響。封鎖措施和供應鏈中斷暫時影響了生產和分銷。眼科診所的減少導致常規視力檢查和診斷延誤。然而,遠距辦公和線上教育導致螢幕使用時間增加,加劇了人們對眼睛疲勞的擔憂。這促使消費者對眼部保健品和防護產品的需求增加。隨著消費者轉向線上購物,電子商務通路的重要性日益凸顯。疫情過後,市場將聚焦在數位互動、市場韌性和預防性眼部護理解決方案。
預計在預測期內,膳食補充劑細分市場將佔據最大的市場佔有率。
預計在預測期內,膳食補充劑領域將佔據最大的市場佔有率。該領域受益於消費者的高接受度和日常服用的便利性。含有維生素、礦物質、類胡蘿蔔素和Omega-3脂肪酸的補充劑被廣泛用於維護視力健康。人們對與老齡化相關的眼科疾病的認知不斷提高,推動了穩定的市場需求。醫療保健趨勢也促進了長期服用補充劑的趨勢。膠囊、軟糖和粉末等多種劑型的出現,也促進了其廣泛應用。
預計在預測期內,線上藥局領域將呈現最高的複合年成長率。
預計在預測期內,線上藥局領域將實現最高成長率。網路普及率和智慧型手機使用量的不斷提高,使得人們更容易存取數位健康平台。消費者更傾向於選擇線上管道,因為其便利性、隱私和價格優勢。訂閱模式和宅配服務有助於提高客戶維繫。線上平台也提供詳細的產品資訊和使用者評價。遠距醫療服務的整合進一步推動了線上購物的發展。
預計北美將在預測期內佔據最大的市場佔有率。人們對眼部健康和預防保健的高度重視支撐了強勁的需求。該地區擁有成熟的營養保健品和膳食補充劑行業。與老齡化相關的視力障礙盛行率不斷上升,推動了產品的普及。完善的法規結構確保了產品品質和消費者信心。眼科診斷技術的進步有助於早期療育。
預計亞太地區在預測期內將實現最高的複合年成長率。快速的都市化和螢幕使用時間的增加導致視力相關問題日益增多。不斷壯大的中產階級人口增加了對健康和保健產品的支出。醫療基礎設施的改善促進了產品的廣泛普及。政府措施正在推動預防性醫療保健和提高營養意識。電子商務平台的擴張正在增強市場滲透率。
According to Stratistics MRC, the Global Eye Health & Vision Support Products Market is accounted for $2.14 billion in 2025 and is expected to reach $3.51 billion by 2032 growing at a CAGR of 7.3% during the forecast period. Eye Health & Vision Support Products encompass consumer-focused solutions formulated to promote healthy eyesight and optimal eye function. This category includes supplements, fortified foods and drinks, ocular care products, and vision protection solutions enriched with essential nutrients and bioactive compounds. These products are developed to reduce eye fatigue, manage dryness, counter digital screen exposure, and slow age-associated visual deterioration. By supporting daily eye comfort and long-term ocular performance, they cater to preventive care needs for diverse populations.
Rise of preventive healthcare
Consumers are increasingly aware of the importance of regular eye care in preventing vision impairment and age-related ocular conditions. Rising screen time, lifestyle-related eye strain, and early onset of vision disorders are encouraging proactive supplementation and eye wellness routines. Governments and healthcare organizations are promoting preventive vision screenings and nutritional support. Advances in diagnostic technologies are enabling early detection of eye conditions, further reinforcing preventive approaches. Functional ingredients such as lutein, zeaxanthin, and omega-3 fatty acids are gaining popularity for long-term eye protection. This shift toward prevention is driving sustained growth across both developed and emerging markets.
Lack of long-term clinical evidence
Many dietary supplements rely on short-duration studies that do not fully demonstrate sustained efficacy. Regulatory authorities often require robust scientific evidence, creating challenges for product approval and claims substantiation. Variability in study outcomes across populations also raises concerns about consistency. Healthcare professionals may hesitate to recommend products lacking strong clinical backing. This uncertainty can reduce consumer confidence and slow adoption rates. As a result, market players must invest heavily in research to strengthen credibility.
Personalized vision care
Advances in genomics, digital eye diagnostics, and AI-driven assessments are enabling tailored eye care solutions. Consumers are increasingly seeking customized supplements and formulations based on age, lifestyle, and specific vision needs. Wearable devices and mobile apps are supporting personalized monitoring of eye health. Companies are leveraging data analytics to develop targeted products for conditions such as dry eye, blue-light exposure, and macular health. This customization enhances treatment effectiveness and customer engagement. As precision healthcare expands, personalized vision care is expected to gain rapid traction.
Product recalls and quality control issues
Eye health supplements and products must adhere to strict safety and quality standards to avoid adverse effects. Contamination, inaccurate labeling, or inconsistent ingredient quality can trigger regulatory actions. Recalls not only result in financial losses but also damage brand reputation. Increasing global scrutiny on nutraceutical manufacturing is raising compliance pressure. Supply chain complexity further elevates the risk of quality lapses. Without robust quality control systems, companies may face long-term trust deficits.
The COVID-19 pandemic had a mixed impact on the eye health and vision support products market. Lockdowns and supply chain disruptions temporarily affected manufacturing and distribution. Reduced access to eye clinics delayed routine vision check-ups and diagnoses. However, increased screen exposure during remote work and online education heightened eye strain concerns. This led to growing consumer interest in eye supplements and protective products. E-commerce channels gained prominence as consumers shifted to online purchases. Post-pandemic, the market is focusing on digital engagement, resilience, and preventive eye care solutions.
The dietary supplements segment is expected to be the largest during the forecast period
The dietary supplements segment is expected to account for the largest market share during the forecast period. This segment benefits from high consumer acceptance and ease of daily consumption. Supplements containing vitamins, minerals, carotenoids, and omega-3s are widely used for maintaining vision health. Rising awareness of age-related eye disorders is fueling consistent demand. Preventive healthcare trends are encouraging long-term supplement usage. The availability of diverse formulations such as capsules, gummies, and powders supports broad adoption.
The online pharmacies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online pharmacies segment is predicted to witness the highest growth rate. Increasing internet penetration and smartphone usage are improving access to digital health platforms. Consumers prefer online channels for convenience, privacy, and competitive pricing. Subscription models and doorstep delivery are enhancing customer retention. Online platforms also provide access to detailed product information and reviews. The integration of teleconsultation services is further boosting online purchases.
During the forecast period, the North America region is expected to hold the largest market share. High awareness of eye health and preventive care supports strong demand. The region has a well-established nutraceutical and dietary supplement industry. Rising prevalence of age-related vision disorders is driving product adoption. Strong regulatory frameworks ensure product quality and consumer trust. Technological advancements in eye care diagnostics support early intervention.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid urbanization and increasing screen exposure are contributing to rising vision-related issues. Growing middle-class populations are spending more on health and wellness products. Improved healthcare infrastructure is supporting wider product availability. Government initiatives are promoting preventive healthcare and nutrition awareness. Expanding e-commerce platforms are enhancing market penetration.
Key players in the market
Some of the key players in Eye Health & Vision Support Products Market include Bausch & Lomb, Johnson & Johnson Vision, Pfizer Inc., EssilorLuxottica S.A., Vitabiotics Ltd., The Cooper Companies, The Nature's Bounty Co., Alcon Inc., Amway International, Nordic Naturals Inc., ZeaVision LLC, Blackmores Limited, Kemin Industries, Inc., NOW Foods, and Herbalife Nutrition Ltd.
In January 2026, Bausch + Lomb Corporation are launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation's (TGF) social media campaign to raise awareness of the disease and its impact by highlighting a glaucoma patient or advocate every day in January.
In December 2025, Pfizer Inc. announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Limited (02196.HK and 600196.SH), a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor agonist currently in Phase 1 development for chronic weight management.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.